Rapt Therapeutics

Rapt Therapeutics company information, Employees & Contact Information

RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.

Company Details

Employees
142
Founded
-
Address
561 Eccles Avenue, South San Francisco,california 94080,united States
Phone
116504899000
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
rapt.com
Keywords
in immunology.
HQ
South San Francisco, California
Looking for a particular Rapt Therapeutics employee's phone or email?

Rapt Therapeutics Questions

News

Phase 2 Topline Data: RPT904 — RAPT Therapeutics to Report Results in Webcast on Oct 20 - Stock Titan

Phase 2 Topline Data: RPT904 — RAPT Therapeutics to Report Results in Webcast on Oct 20 Stock Titan

RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 for Chronic Spontaneous Urticaria on October 20, 2025 - Quiver Quantitative

RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 for Chronic Spontaneous Urticaria on October 20, 2025 Quiver Quantitative

RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU) - Sahm

RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU) Sahm

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences - Yahoo Finance

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences Yahoo Finance

45.7% UAS7=0 at Week 16 — RAPT & Jeyou's RPT904 Phase 2 shows durable efficacy vs omalizumab - Stock Titan

45.7% UAS7=0 at Week 16 — RAPT & Jeyou's RPT904 Phase 2 shows durable efficacy vs omalizumab Stock Titan

RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria - GlobeNewswire

RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria GlobeNewswire

Clinical-Stage Biotech RAPT Therapeutics Lines Up Four Major Wall Street Healthcare Conference Presentations - Stock Titan

Clinical-Stage Biotech RAPT Therapeutics Lines Up Four Major Wall Street Healthcare Conference Presentations Stock Titan

Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy - ACS Publications

Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy ACS Publications

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire

RAPT Stock Price and Chart — NASDAQ:RAPT - TradingView

RAPT Stock Price and Chart — NASDAQ:RAPT TradingView

Rapt Therapeutics (RAPT) Stock Price, News & Analysis - MarketBeat

Rapt Therapeutics (RAPT) Stock Price, News & Analysis MarketBeat

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody - GlobeNewswire

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody GlobeNewswire

RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - FinancialContent

RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference FinancialContent

RAPT - Rapt Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

RAPT - Rapt Therapeutics, Inc. Latest Stock News & Market Updates Stock Titan

Top Rapt Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant